Patents by Inventor Antoine Thomas

Antoine Thomas has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11896042
    Abstract: A novel yeast extract having from 25 to 55 wt % 5?-ribonucleotides, including 5 to 20 wt % adenosine 5?-monophosphate (5?-AMP) and 5 to 20 wt % guanosine 5?-monophosphate (5?-GMP) in a 5?-AMP/5?-GMP ratio ranging from 0.85 to 1.25, the weight percentages being expressed in relation to the dry weight of the yeast extract. Also a process of using such an extract for the masking of bitter and sour tastes and of undesirable sweetener, protein and metallic notes in a product.
    Type: Grant
    Filed: November 12, 2018
    Date of Patent: February 13, 2024
    Assignee: LESAFFRE ET COMPAGNIE
    Inventors: Hélène Jolivet, Rudy Menin, Antoine Thomas
  • Publication number: 20210076722
    Abstract: A novel yeast extract having from 25 to 55 wt % 5?-ribonucleotides, including 5 to 20 wt % adenosine 5?-monophosphate (5?-AMP) and 5 to 20 wt % guanosine 5?-monophosphate (5?-GMP) in a 5?-AMP/5?-GMP ratio ranging from 0.85 to 1.25, the weight percentages being expressed in relation to the dry weight of the yeast extract. Also a process of using such an extract for the masking of bitter and sour tastes and of undesirable sweetener, protein and metallic notes in a product.
    Type: Application
    Filed: November 12, 2018
    Publication date: March 18, 2021
    Applicant: LESAFFRE ET COMPAGNIE
    Inventors: Hélène JOLIVET, Rudy MENIN, Antoine THOMAS
  • Patent number: 8946476
    Abstract: The present patent application relates to an alternative process for the preparation of amino derivatives. In particular, the present application relates to an improved process for the manufacture of Lacosamide (LCM), (R)-2-acetamido-N-benzyl-3-methoxypropion-amide, which is useful as an anticonvulsive drug. In a particular aspect, the present invention relates to a process of manufacture of optically enriched (R)-2-acetamido-N-benzyl-3-methoxypropion-amide (I) comprising resolution of 2-acetamido-N-benzyl-3-methoxypropion-amide (II).
    Type: Grant
    Filed: November 6, 2009
    Date of Patent: February 3, 2015
    Assignee: UCB Pharma GmbH
    Inventors: Didier Bouvy, Alain Merschaert, Véronique Pinilla, Joerg Hamann, Ralf Kanzler, Antoine Thomas
  • Patent number: 8338621
    Abstract: The present invention relates to alternative processes for the preparation of 2-oxo-1-pyrrolidine derivatives of formula (I) Particularly, the present invention relates to alternative processes for the synthesis of levetiracetam, brivaracetam and seletracetam.
    Type: Grant
    Filed: December 19, 2006
    Date of Patent: December 25, 2012
    Assignee: UCB S.A.
    Inventors: John Surtees, Didier Bouvy, Antoine Thomas, Yves Combret, Michael Frank, Gunther Schmidt, Guy Duchene
  • Publication number: 20110263899
    Abstract: The present patent application relates to an alternative process for the preparation of amino derivatives. In particular, the present application relates to an improved process for the manufacture of Lacosamide (LCM), (R)-2-acetamido-N-benzyl-3-methoxypropion-amide, which is useful as an anticonvulsive drug. In a particular aspect, the present invention relates to a process of manufacture of optically enriched (R)-2-acetamido-N-benzyl-3-methoxypropion-amide (I) comprising resolution of 2-acetamido-N-benzyl-3-methoxypropion-amide (II).
    Type: Application
    Filed: November 6, 2009
    Publication date: October 27, 2011
    Applicant: UCB PHARMA GMBH
    Inventors: Didier Bouvy, Alain Merschaert, Véronique Pinilla, Joerg Hamann, Ralf Kanzler, Antoine Thomas
  • Publication number: 20080009638
    Abstract: The present invention relates to alternative processes for the preparation of 2-oxo-1-pyrrolidine derivatives of formula (I) Particularly, the present invention relates to alternative processes for the synthesis of levetiracetam, brivaracetam and seletracetam.
    Type: Application
    Filed: December 19, 2006
    Publication date: January 10, 2008
    Applicant: UCB S.A.
    Inventors: John Surtees, Didier Bouvy, Antoine Thomas, Yves Combert, Michael Frank, Gunther Schmidt, Guy Duchene